2024 · Bioinformatics · Oxford University Press · added 2026-04-21
Motivation: Drug–target interaction (DTI) prediction is a relevant but challenging task in the drug repurposing field. In-silico approaches have drawn particular attention as they can reduce associate Show more
Motivation: Drug–target interaction (DTI) prediction is a relevant but challenging task in the drug repurposing field. In-silico approaches have drawn particular attention as they can reduce associated costs and time commitment of traditional methodologies. Yet, current state-of-the-art methods present several limitations: existing DTI prediction approaches are computationally expensive, thereby hindering the ability to use large networks and exploit available datasets and, the generalization to unseen datasets of DTI prediction methods remains unexplored, which could Show less
2024 · Current Drug Targets · Bentham Science · added 2026-04-21
Background: Drug discovery is a complex and expensive procedure involving several
timely and costly phases through which new potential pharmaceutical compounds must pass to get
approved. One of these Show more
Background: Drug discovery is a complex and expensive procedure involving several
timely and costly phases through which new potential pharmaceutical compounds must pass to get
approved. One of these critical steps is the identification and optimization of lead compounds,
which has been made more accessible by the introduction of computational methods, including
deep learning (DL) techniques. Diverse DL model architectures have been put forward to learn the
vast landscape of interaction between proteins and ligands and predict their affinity, helping in the
identification of lead compounds.
ARTICLE HISTORY
Objective: This survey fills a gap in previous research by comprehensively analyzing the most
commonly used datasets and discussing their quality and limitations. It also offers a comprehensive classification of the most recent DL methods in the context of protein-ligand binding affinity
prediction (BAP), providing a fresh perspective on this evolving field.
Received: June 07, 2024
Revised: August 11, 2024
Accepted: August 19, 2024
Methods: We thoroughly examine commonly used datasets for BAP and their inherent characteristics. Our exploration extends to various preprocessing steps and DL techniques, including graph
neural networks, convolutional neural networks, and transformers, which are found in the literaDOI:
10.2174/0113894501330963240905083020 ture. We conducted extensive literature research to ensure that the most recent deep learning approaches for BAP were included by the time of writing this manuscript.
Results: The systematic approach used for the present study highlighted inherent challenges to
BAP via DL, such as data quality, model interpretability, and explainability, and proposed considerations for future research directions. We present valuable insights to accelerate the development
of more effective and reliable DL models for BAP within the research community.
Conclusion: The present study can considerably enhance future research on predicting affinity between protein and ligand molecules, hence further improving the overall drug development process. Show less